Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future
-
* Corresponding author: Philipp Schuetz Philipp.Schuetz@post.harvard.edu
BMC Medicine 2011, 9:107 doi:10.1186/1741-7015-9-107
Accesses
- Last 30 days: 1138 accesses
- Last 365 days: 8466 accesses
- All time: 8466 accesses
Cited by
BioMed Central: 2 citations
|
suPAR as a prognostic biomarker in sepsis Katia Donadello, Sabino Scolletta, Cecilia Covajes, Jean-Louis Vincent BMC Medicine 2012, 10:2 (5 January 2012) This article is part of a collection on Clinical biomarkers Donadello and colleagues review the clinical utility of suPAR as a biomarker for sepsis, and discuss how it can be used to monitor response to treatment in critically ill patients.
|
|
MH Wilke, RF Grube, KF Bodmann European Journal of Medical Research 2011, 16:543-548 (2 December 2011) |